Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 10, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Biomarker profiling for lupus nephritis.

Yajuan Li1, Xiangdong Fang, Quan-Zhen Li

  • 1Department of Immunology and Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Genomics, Proteomics & Bioinformatics
|June 5, 2013
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Progress of Gout Prediction Models Based on Multi-source Data.

Current rheumatology reviews·2026
Same author

Methylation entropy as a novel dimension in liquid biopsy: enhanced multimodal framework for cancer detection and tissue-of-origin classification.

Journal of translational medicine·2026
Same author

Innate and adaptive immune features associated with immune-related adverse events.

Journal for immunotherapy of cancer·2025
Same author

DKK3, regulated by FOXF1-EZH2 axis, takes action on tubular epithelial cells senescence to trigger glomerular endothelial cells ferroptosis involving in renal fibrosis.

Mechanisms of ageing and development·2025
Same author

Angiotensin-(1-7) Mitigates Progression from Acute Kidney Injury to Chronic Kidney Disease Via Renin-Angiotensin System Modulation in a Murine Model.

Inflammation·2025
Same author

The novel ferroptosis-inducing molecule can inhibit the progression of BC by regulating the ubiquitination of UHRF1.

Epigenomics·2025

Lupus nephritis (LN), a severe form of systemic lupus erythematosus (SLE), has identified numerous biomarkers through genomics and proteomics. These discoveries aid in predicting and treating this complex autoimmune disease.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE), leading to significant patient morbidity and mortality.
  • The development of LN involves a complex interplay of genetic, epigenetic, and environmental factors.

Purpose of the Study:

  • To review recent advancements in identifying biomarkers for lupus nephritis.
  • To highlight the role of omics-based techniques in understanding LN pathogenesis and potential therapeutic targets.

Main Methods:

  • Genomic approaches to identify genetic predispositions and variations associated with SLE and LN.
  • Proteomic approaches to discover protein-based biomarkers for disease prediction and monitoring.
  • Transcriptomic data analysis to understand gene expression patterns in LN.

More Related Videos

Antibody Profiling by Luciferase Immunoprecipitation Systems (LIPS)
12:19

Antibody Profiling by Luciferase Immunoprecipitation Systems (LIPS)

Published on: October 7, 2009

Related Experiment Videos

Last Updated: May 10, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Antibody Profiling by Luciferase Immunoprecipitation Systems (LIPS)
12:19

Antibody Profiling by Luciferase Immunoprecipitation Systems (LIPS)

Published on: October 7, 2009

Main Results:

  • Numerous genetic and proteomic variations linked to SLE and LN have been identified.
  • Omics technologies have significantly improved the understanding of the molecular underpinnings of LN.
  • Biomarker discovery is crucial for early diagnosis, prognosis, and targeted therapies.

Conclusions:

  • Genomics and proteomics are powerful tools for unraveling the complexities of lupus nephritis.
  • Continued research in biomarker identification holds promise for improved patient outcomes in SLE.
  • Understanding molecular pathways is key to developing novel therapeutic strategies for LN.